상세 보기
Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy
- Kwon, Yong Soo;
- Koh, Won-Jung;
- Suh, Gee Young;
- Chung, Man Pyo;
- Kim, Hojoong;
- 외 1명
WEB OF SCIENCE
41SCOPUS
41초록
Background: The risk of drug-induced hepatotoxicity (DIH) during treatment for tuberculosis (TB) in patients who are seropositive for the hepatitis C virus (HCV) is not clear. We evaluated whether HCV-seropositive patients are at a, higher risk of DIH than control subjects during treatment for TB with standard short-course regimens. Methods: Fifty-four HCV-seropositive patients with newly diagnosed active TB who were treated with isoniazid, rifampin, ethambutol, and/or pyrazinamide were included in the study population. Ninety-seven HCV-seronegative patients were selected as control subjects. Results: Forty HCV-seropositive patients (74%) and 82 control subjects (85%) received an initial treatment regimen that included pyrazinamide. Twenty-two HCV-seropositive patients (41%) and 19 control subjects (20%) exhibited elevated liver enzyme levels during TB treatment, including transient elevation of transaminase. DIH, defined as a liver transaminase level >= 120 IU/L, occurred more frequently in HCV-seropositive patients (7 of 54 patients, 13%) than in control subjects (4 of 97 patients, 4%). Isoniazid and rifampin were reintroduced after the liver transaminase level returned to baseline in five HCV-seropositive patients exhibiting DIH, and all these retrials proved to be successful. Conclusions: These findings suggest that treatment for TB in HCV-seropositive patients could be pursued in the usual manner, using standard short-course regimens, with the condition that monthly liver function tests are carefully performed.
키워드
- 제목
- Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy
- 저자
- Kwon, Yong Soo; Koh, Won-Jung; Suh, Gee Young; Chung, Man Pyo; Kim, Hojoong; Kwon, O. Jung
- 발행일
- 2007-03
- 유형
- Article
- 저널명
- Chest
- 권
- 131
- 호
- 3
- 페이지
- 803 ~ 808
- 언어
- ENG
- 출판사
- Elsevier Inc.
- 발행국가
- 네덜란드
- 분량
- 6 페이지
- ISSN
- E 1931-3543
P 0012-3692